BioNTech: “We can’t do it alone: ​​other vaccines are approved”

01/01/2021 Health, Italy



[ad_1]

The head of BioNTech, Ugur Sahin, warned that if other vaccines against coronavirus your company alone will not be approved immediately in Europe will not be able to meet the needs. «The situation is not good. A gap has been created because no other vaccines have been approved and we have to cover the hole with ours, “he explained in an interview to the German weekly Spiegel.

Four days after V-Day, the vaccination campaign in Europe could encounter its first difficulties. Although British pharmacist AstraZeneca has no doubts about the efficacy of its vaccine, it states that 95% effective, Ema already has definite unlikely green light in January. This causes a lot of problems, especially for Italy which had already bought 400 million doses last June, together with Germany, France and the Netherlands.

German Health Minister Jens Spahn urged the EMA to quickly approve the vaccine developed by the University of Oxford and AstraZeneca as well, but the timing for approval of the latter remains uncertain.